With your continued support, the Foundation can deepen its commitment to prioritizing innovations that give people new hope when it comes to cancer.
We know cancer prevention and early detection can lead to more effective, efficient treatment and a better quality of life for patients and their loved ones. Innovation is changing the way we think about how we detect and treat cancer and will make it easier for Americans to check their health.
With your support, the Foundation has to date invested nearly $46 million toward advances in cancer prevention research and early detection innovations, improving people’s lives in communities around the world.
With your continued support, the Foundation can deepen its commitment to prioritizing innovations that give people new hope when it comes to cancer.
In April, the Prevent Cancer Foundation invited thought leaders from industry and academia to form its first-ever Innovation Council to explore the political, societal and industry factors shaping the future of cancer prevention and early detection.By identifying the most relevant innovations now and the ones coming down the pike, the Foundation can proactively fund potential areas of groundbreaking research, advocate for policies and invest in programs to increase better outcomes. and invest in programs to increase better outcomes.
Photo: Sharon Cook (second from right), with Doug Burr, Prevent Cancer Foundation CEO Jody Hoyos and Jack Stark at the Prevent Cancer Annual Gala
I have lost my mother, grandmother, cousin, and my husband to cancer. Each loss reinforced that the “cure” to cancer is prevention and early detection. Studies consistently show that the earlier cancer is detected, the greater the chance for survival. That fact is what makes the work of the Prevent Cancer Foundation essential to reducing cancer fatalities.
The toll cancer has taken on my family is great. We feel it every holiday, birthday, wedding, or other special occasion. It’s what fuels my passion for supporting ways to make cancer prevention easier and more affordable for all.
In my own philanthropic journey, I have discovered that without passion for the mission, remaining dedicated to the cause is difficult. Passion is part of what keeps you committed to a goal, willing to do all you can to accomplish it. Donating to the Prevent Cancer Foundation and serving on its board of directors are in alignment with my personal mission of raising awareness that a cancer diagnosis does not have to be a death sentence.
I admire the passion and commitment of the Prevent Cancer Foundation team. They are creative, inclusive, and forward-thinking. They face the financial and political challenges of their work with grace and integrity, every single day. I credit this ethic to the Foundation’s founder, Bo Aldigé, a strong, determined, and knowledgeable leader whose own passion for ending cancer has personal ties similar to mine—Bo was compelled by the memory of her late father to start the Prevent Cancer Foundation nearly 40 years ago. The Foundation’s CEO, Jody Hoyos, has harnessed this passionate history and is working to usher in a new era of innovation. Her considerable experience in healthcare philanthropy and generational giving is a tremendous asset to making this possible.
As both a donor and board member, it’s important for me to find ways to communicate in a manner that touches both the current and future generations of donors and other supporters of the Foundation. Each group may have different priorities but are likely to be equally passionate about the mission.
As someone who knows firsthand the toll that being a caregiver for a cancer patient can take, it is meaningful to me that as a board member, I am helping spread the message of the dramatic emotional and financial savings that can be realized if we expand federal support for cancer prevention and early detection. Expanded screening leads to fewer cancers. Fewer cancers mean more resources are available to invest in innovative treatments and other ways to support care for patients and families. This is rewarding not just for me, but for everyone.
In January 2023, the Foundation awarded eight $100,000 two-year grants to projects focused on the prevention or early detection of blood, breast, colorectal, lung, prostate, and skin cancers, including one in memory of former Foundation board member, Congressman Victor “Vic” Fazio (D-Calif.), who died of melanoma in 2022.
Francisco Cartujano, M.D.,
Advancing Lung Cancer Screening Among Latinos One Text at a Time
Richard C. Devereaux Outstanding Young Investigator Award
Assistant Professor of Research
Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, N.Y.
Brandon Gheller, Ph.D.
Dietary Intervention for Clonal Hematopoiesis, Myelodysplasia and Leukemia
Awesome Games Done Quick
Postdoctoral Research Fellow
Boston Children’s Hospital, Boston, Mass.
Maayan Levy, Ph.D.
Designing Metabolite-Based Prevention in Lynch Syndrome
Stohlman Family Grant in memory of Richard Stohlman and Margaret Weigand
Assistant Professor of Microbiology
Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa.
Caner Saygin, M.D.
Dissecting the Evolution of Clonal Hematopoiesis to Prevent Acute Leukemias
Awesome Games Done Quick
Assistant Professor of Medicine
University of Chicago, Chicago, Ill.
Srividya Swaminathan, Ph.D.
Targeting the Long Isoform of the Prolactin Receptor to Prevent B-Lymphomas
Congressional Families Program: Tribute to The Honorable Vic Fazio
Assistant Professor, Dept. of Systems Biology
Beckman Research Institute at City of Hope, Duarte, Calif.
Veronica Rotemberg, M.D., Ph.D.
Quantifying the Impact of Skin Tone on Diagnostic Prediction
Vic Fazio Memorial Fund
Director, the Tow Foundation Skin Cancer Informatics Program
Memorial Sloan-Kettering Cancer Center, New York, N.Y.
Ester Villalonga Olives, Ph.D., Ms.C.
Adaptation of Project HEAL for Hispanic/Latino Immigrants
Awesome Games Done Quick
Assistant Professor, Practice, Sciences and Health Outcomes Research
University of Maryland, Baltimore, Md.
Michelle S. Williams, Ph.D., M.S.P.H., MPH, MCHES
A Multicomponent Lung Cancer Screening Awareness mHealth
The Shure Family Charitable Foundation
Assistant Professor, Global and Community Health
George Mason University, Fairfax, Va.
Dr. Bernard Levin and Carolyn R. Aldigé
During his tenure as Scientific Review Panel Co-chair, Dr. Levin, professor emeritus and former division head and vice president of population sciences for the University of Texas MD Anderson Cancer Center, has been a champion in ushering in a generation of cancer prevention scientists. Most recently, Dr. Levin served as chair of the American Cancer Society’s National Advisory Task Force on Colorectal Cancer.
Since 2015, fellows from low- and middle-income countries have received technical training grants awarded jointly by the Prevent Cancer Foundation and the Union for International Cancer Control (UICC). Awardees study cancer prevention and early detection at top research and cancer institutes around the world, then return to their home countries to disseminate their new knowledge and train their colleagues. The UICC fellowships are generously supported by the FitzGerald Family.
Bède Bigirimana,
Kamenge University Hospital Center, Burundi
General Hospital of Grand Yoff, Dakar, Senegal
Building Capacity in Diagnostic Immuno-his- tochemistry Techniques for Cervical Cancer
Ivana Blazic, M.D., Ph.D.,
Clinical Hospital Center Zemun, Serbia
Ramon and Cajal University Hospital, Spain
Epidemiological and Clinical Analysis of Early Onset of Colorectal Cancer
Alice Nanelin Guingané, M.D., MPH,
Chu Bogodogo, Hepato-gastro Enterology Service, Ouagadougou, Burkina Faso
Savory Metropolis Hospital Center, Chambery, France
Endoscopic Screening and Early Diagnosis of Colorectal Cancer
Grâce Aurélie Majoumo Mukam,
Yaoundé Gynecology, Obstetrics and Pediatrics Hospital, Cameroon
Pathological Anatomy Laboratory Beauvais Hospital Center, France
Building Capacity in Diagnostic Testing for Human Papillomavirus